Tirzepatide represents a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://woodyawsf252386.dm-blog.com/40822568/tirzepatide-a-game-changer-for-type-2-diabetes